Literature DB >> 11696094

Bactericidal activity of citrate against Gram-positive cocci.

Y L Lee1, L Thrupp, J Owens, T Cesario, E Shanbrom.   

Abstract

AIMS: Coagulase-negative staphylococci (CNS) are now important nosocomial pathogens and are usually resistant to multiple antibiotics. Citrate is an alternative antimicrobial product which has been used as a preservative. METHODS AND
RESULTS: In this pilot study the bactericidal activity of Na citrate against 10 isolates of CNS and 6 other gram-positive pathogens was examined and compared with that of Na lactate.
CONCLUSIONS: All staphylococci tested were susceptible (> or = 2 log(10) killing) to citrate at 6.25-25 mg ml(-1). Na lactate showed only modest killing at 50 or 100 mg ml(-1). SIGNIFICANCE AND IMPACT OF THE STUDY: Citrate may warrant broader evaluation as an antimicrobial additive such as in topical agents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696094     DOI: 10.1046/j.1472-765x.2001.01011.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  3 in total

1.  Transport and metabolism of citrate by Streptococcus mutans.

Authors:  Bryan Korithoski; Kirsten Krastel; Dennis G Cvitkovitch
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

2.  Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates.

Authors:  Stefan Riedel; Alan Junkins; Paul D Stamper; Gretchen Cress; John A Widness; Gary V Doern
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

3.  Genetic evidence for an alternative citrate-dependent biofilm formation pathway in Staphylococcus aureus that is dependent on fibronectin binding proteins and the GraRS two-component regulatory system.

Authors:  Robert M Q Shanks; Michael A Meehl; Kimberly M Brothers; Raquel M Martinez; Niles P Donegan; Martha L Graber; Ambrose L Cheung; George A O'Toole
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.